The natural susceptibility of 74 Plesiomonas shigelloides strains isolated from humans (n ‫؍‬ 50), water (n ‫؍‬ 22) and animals (n ‫؍‬ 2) to 71 antibiotics was examined. MICs were performed using a microdilution procedure with Mueller-Hinton broth and an inoculum of 1 ؋ 10 6 cfu/mL. 
Introduction
Plesiomonas shigelloides comprises a distinct group of Gram-negative, thermotolerant, motile and pleomorphic microorganisms being weakly related to species of Enterobacteriaceae and Vibrionaceae.
1 P. shigelloides can be isolated from humans, numerous animals such as fish, birds and insects, 2 and several aquatic environments (e.g. rivers, fresh water lakes, puddles, sludge). 3 In humans, plesiomonadae have been implicated as a cause of gastroenteritis infections in adults and children, in particular in tropical and subtropical regions. [4] [5] [6] Diarrhoea in overseas travellers in Japan is likely to be predominantly associated with Plesiomonas, 7 and the organism was also shown to cause meningitis, osteomyelitis, sepsis and other non-diarrhoeal diseases. 5 Pathogenicity was also demonstrated in animal models 8 and several virulence-associated factors have been described. [9] [10] [11] [12] Despite their occurrence in clinical specimens, little is known about the antimicrobial susceptibilities and particularly the natural antibiotic susceptibilities and resistances of Plesiomonas. Moreover, there is some confusion in the literature about the resistance of P. shigelloides to certain -lactam antibiotics like penicillins. 1 There is strong evidence that this confusion has to be attributed to different conditions in susceptibility testing. In a previous study we showed that different media and inocula dramatically influenced the MICs for plesiomonadae of numerous -lactam antibiotics. 13 The aim of the present paper was to create a database of the natural susceptibility of P. shigelloides strains originating from different sources to a wide range of antibiotics. To investigate whether and to what extent MICs of non--lactams were dependent on the medium and inoculum, 10 representative strains were tested with these antibiotics using different media and inocula.
Materials and methods

Bacterial strains
Seventy-four plesiomonadae isolated from humans (n ϭ 50), water (n ϭ 22) and animals (n ϭ 2) were examined. An overview on the origin of the strains tested is shown in 
Identification
The identification of the strains was confirmed using a commercial identification system for Enterobacteriaceae and several other Gram-negative bacteria (Micronaut-E, Merlin-Diagnostika, Bornheim, Germany). This identification system includes biochemical key reactions for Enterobacteriaceae and related taxa of clinical significance (including P. shigelloides). The inoculum for the identification tests was prepared from overnight cultures on IsoSensitest agar (Oxoid, Basingstoke, UK) in physiological saline and was 10 6 cfu/mL. The incubation time was 22 h, the incubation temperature was 37ЊC.
Antibiotics and antibiotic susceptibility testing
For all the strains, antibiotic susceptibility was determined by a microdilution procedure in cation-adjusted MuellerHinton broth (CAMHB; Difco Laboratories, Detroit, MI, USA) according to the NCCLS standard, using a slightly increased inoculum of 1 ϫ 10 6 cfu/mL. This inoculum is conceivable under normal testing conditions and was chosen to clarify the resistance potential of Plesiomonas. MICs were read visually after inoculation of antibioticcontaining microtitre plates (Merlin-Diagnostika) with 100 L of the appropriate bacterial suspensions, and incubation for 22 h at 37ЊC. The MIC was defined as the lowest antibiotic concentration that inhibited visible growth. Ten representative plesiomonadae of clinical (n ϭ 4), aquatic (n ϭ 4) and mammalian origin (n ϭ 2) were tested to all non--lactam antibiotics using CAMHB, Mueller-Hinton broth (Oxoid) and IsoSensitest broth (Oxoid), and four different inocula (1 ϫ 10 4 , 1 ϫ 10 5 , 1 ϫ 10 6 and 1 ϫ 10 7 cfu/mL). For preparation of the inocula, 18-20 h cultures grown on sheep blood agar (Oxoid) were used. An inoculum of 1 ϫ 10 9 cfu/mL was adjusted in physiological saline and diluted to yield the final inoculum. Viable cell counting was undertaken to verify the prepared inocula (three-fold determinations). All susceptibility trials were carried out in duplicate. The antibiotics were kindly provided to MerlinDiagnostika by the manufacturers.
Evaluation of natural antibiotic susceptibility
Plotting the MIC of a particular antibiotic for one species against the number of strains found with the respective MIC usually results in a bimodal distribution. Generally, one peak with relatively low MICs represents the natural population and one peak with higher MICs represents the strains with acquired (secondary) resistance. This is not valid for plesiomonadae and some -lactams. 13 Analysis of the MIC distribution for all strains of one species of each antibiotic permitted determination of the biological thresholds, which limit the natural population at high MICs but not those strains with secondary resistance. Whether the MICs for the natural population were above or below the breakpoints of the standards, which assess the clinical susceptibility, was investigated. When the natural population was susceptible or intermediate according to the cited standard, it was described as naturally susceptible or naturally intermediate, respectively. When the natural population was clinically resistant, it was described as naturally (intrinsically) resistant. The method has been described in detail previously. [14] [15] [16] In the present study, breakpoints according to the NCCLS 17 valid for Enterobacteriaceae, P. aeruginosa and other non-Enterobacteriaceae, Neisseria gonorrhoeae and staphylococci were applied. For antibiotics for which NCCLS clinical assessment criteria do not exist, breakpoints according to German, 18 French 19 or Swedish 20 standards were employed. Breakpoints for apramycin, ribostamycin and lividomycin A were used as published recently. 
Results
The MIC distributions for the Plesiomonas strains tested are presented in Table 2 . Generally, there were no sig- nificant differences in susceptibility to most antibiotics among human isolates and strains from other sources. All plesiomonadae were naturally susceptible or naturally susceptible and intermediate to tetracyclines, several aminoglycosides, aminopenicillins in combination with -lactamase inhibitors, all cephalosporins except cefoperazone, ceftazidime and cefepime, carbapenems, aztreonam, quinolones, trimethoprim, sulfamethoxazole, azithromycin, chloramphenicol, nitrofurantoin and fosfomycin. Uniform natural resistance was found to all penicillins in the absence of -lactamase inhibitors, roxithromycin, clarithromycin, lincosamides, streptogramins, glycopeptides and fusidic acid. Plesiomonas strains were naturally resistant and intermediate to streptomycin, erythromycin and rifampicin. Strains with natural susceptibility and resistance were found for some antibiotics, e.g. apramycin, ribostamycin, lividomycin A and co-trimoxazole. There were two susceptibility patterns to several -lactams. Whereas some strains were highly susceptible to piperacillin/tazobactam, aztreonam and all cephalosporins except cefoperazone, cefoxitin and first-generation cephalosporins (pattern 1), there were others with a significantly decreased susceptibility to these -lactams (pattern 2). The clinical assessment of the natural population of the latter strains led to several isolates with a resistance to cefoperazone, ceftazidime and cefepime. Pattern 2 was more frequently detected in human than in aquatic strains (Table 2) .
805
Quality assurance
The MIC data of all antibiotics were reproducible for E. coli ATCC 25922 and P. aeruginosa ATCC 27853. The MICs for these strains were within the control limits for susceptibility testing according to NCCLS criteria (data not shown).
Dependency on medium and inoculum
Testing of non--lactam antibiotics with different inocula generally did not influence the MICs, using inocula of 1 ϫ 10 4 , 1 ϫ 10 5 or 1 ϫ 10 6 cfu/mL. Using an inoculum of 1 ϫ 10 7 cfu/mL, some plesiomonadae (and also E. coli ATCC 25922 and P. aeruginosa ATCC 27853) showed higher MICs for several unrelated antibiotics, such as the quinolones and antifolates, but the decrease in susceptibility was generally low (two or three MIC dilution steps). These dependencies on the inoculum were obtained in all media applied. MICs achieved with the two MuellerHinton media and IsoSensitest broth were nearly identical. However, the MICs of tetracyclines and macrolides in IsoSensitest broth were two dilution steps higher than in Mueller-Hinton media (data not shown).
Discussion
Despite the clinical significance of P. shigelloides for man there is limited information available about its antimicrobial susceptibility. In recent years, most studies dealing with the antibiotic susceptibility of Plesiomonas have included only a limited number of antimicrobials and/or only few strains. [22] [23] [24] [25] [26] [27] [28] Therefore, the main aim of the present study was to create a database on the susceptibility to a wide range of antimicrobial agents of a large Plesiomonas population, containing clinical and environmental strains.
Concerning -lactam antibiotics, it was shown that P. shigelloides was naturally resistant to benzylpenicillin, oxacillin, amoxicillin, acylaminopenicillins (piperacillin, mezlocillin, azlocillin) and ticarcillin. It is most likely that discrepancies in the extent of resistance to these agents seen in several studies have to be attributed to the extreme inoculum dependency of the appropriate MICs, as shown recently. 13 It is most remarkable that the two susceptibility patterns to several cephalosporins, piperacillin/tazobactam and aztreonam, which were the same as in our previous study, 13 were also found for all strains with the susceptibility pattern of decreased MICs (pattern 1). Using an inoculum of 1 ϫ 10 7 cfu/mL, all plesiomonadae, including one strain being susceptible to acylaminopenicillins and most susceptible to benzylpenicillin (see Table 2 ), showed the susceptibility pattern of increased MICs (pattern 2, data not shown). The phenotypic data of the present and our previous study 13 indicate the presence of a novel mechanism of -lactamase expression and the presence of -lactamase(s) in all plesiomonadae. Resistance to amoxicillin and ticarcillin but susceptibility to co-amoxiclav might be due to chromosomally encoded class A enzymes, probably similar to those that can be found in Klebsiella spp. In a recent study, Avison et al. 28 examined the production of -lactamases in 20 Plesiomonas strains and found three different enzymes in 10 of these strains, i.e. a group 2c carbenicillinase, a group 2d oxacillinase and a group 2a enzyme. Each of the 10 -lactamase-positive strains contained one of these enzymes. Because all the strains tested showed a similar antibiogramm it might be possible that failure to detect -lactamases in all the strains is due to the 'individual state' of the bacterial culture during the -lactamase preparation. It should be noted that although all plesiomonadae examined so far are capable of showing resistance to certain penicillins and expressing two cephalosporin susceptibility patterns, there is a high strainto-strain variation, as far as inoculum and medium dependency is concerned. 13 From the data of the present and our previous study, 13 there is evidence that -lactamase expression in plesiomonadae might be connected with 'quorum sensing'. 29 Generally, during this process bacterial signals act at high cell density due to accumulations above a threshold level and mediate changes in gene expression. 29 Quorum sensing can regulate a variety of cellular events and it was shown that the expression of the chromosomally encoded 2-N-acetyltransferase involved in the acetylation of peptidoglycan of Providencia stuartii was strongly influenced by its cell density. 30 Interestingly, within the Enterobacteriaceae, Providencia and Proteus spp. might represent the closest neighbours of Plesiomonas 31 and it was found that Providencia strains susceptible to cephalosporins with an inoculum of 5 ϫ 10 5 cfu/mL were resistant to all cephalosporins with an inoculum of 5 ϫ 10 6 cfu/mL.
14 In contrast to -lactam antibiotics, there were no or only minor inoculum and medium dependencies seen in the susceptibility testing of non--lactams. This gives further support to the idea that specific -lactamases rather than other mechanisms are responsible for the -lactam susceptibility patterns described. The natural resistance of P. shigelloides to most macrolides, lincosamides, streptogramins, glycopeptides and fusidic acid is likely to be attributed to the Plesiomonas outer membrane, which might prevent the entry into the cell of most of these antibiotics. The natural resistance patterns observed to these non--lactams are a common feature of many Gram-negative organisms and can be found in nearly all Enterobacteriaceae but are not a general feature of Vibrionaceae. For example, Vibrio cholerae is highly susceptible to erythromycin 32 and this macrolide is used successfully in the treatment of cholera and some other infections due to Vibrio spp. 33 Thus, it is likely that the Plesiomonas cell envelope resembles the Enterobacteriaceae cell wall rather than that of several Vibrio spp. This is in agreement with some data on the composition of the Plesiomonas cell envelope, which contains lipid A and, in contrast to species of Vibrionaceae, the enterobacterial common antigen. 1 The results of the present and our previous study 13 show that P. shigelloides is naturally resistant to several antibiotics. Because the organism has the natural potential for resistance to a wide range of -lactams under conceivable testing conditions it might be useful to describe Plesiomonas as naturally resistant to a variety of -lactams, i.e. all penicillins but also some cephalosporins, like cefoperazone, ceftazidime and cefepime, and to renounce the use of these -lactams in the treatment of severe Plesiomonas infections. It should be discussed whether individual breakpoints for Plesiomonas should be included in the standards of antimicrobial susceptibility testing. The extreme inoculum dependency seen for numerous -lactams might give insights into a new mechanism of -lactamase expression. Several studies on the -lactamase expression of P. shigelloides have already started. Although mechanisms other than -lactamases cannot be excluded it is unlikely that they play an important part in the susceptibility to -lactams, according to the data from the present and our previous study. 13 The data described represent a database about the natural susceptibility of P. shigelloides strains to a wide range of antimicrobial agents, which can be used for the validation of susceptibility test results of these unusual proteobacteria.
